Great Lakes and Vivonoetics to help Roche monitor infants in a drug trial

Vivonoetics, in partnership with Great Lakes NeuroTechnologies, will be providing advanced respiratory assessment to the Roche FIREFISH study.

GLNeuroTech secures $1.9M to improve treatment for Parkinson’s disease patients

The company's technology combines wearable motor symptom-sensing and a deep brain stimulation (DBS) platform into a single integrated system.